ANIK
$42.51
Anika Therapeutics
$2.52
6.30%
ANIK
Earnings Whisper ®
N/A
2nd Quarter June 2021
Consensus:  $0.03
Revenue:  $34.76 Mil
Thursday
Aug 5
4:05 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch
Latest EPS
Thursday, May 06, 2021

What do you expect when ANIK reports earnings?
Beat
Meet
Miss

Where is ANIK's stock price going from here?
Up
Flat
Down
Stock chart of ANIK
Analysts
Summary of analysts' recommendations for ANIK
Score
Grade
Pivots
Resistance
$46.95
$45.00
$43.75

$41.80

Support
$40.55
$38.60
$37.35
Tweet
Growth
Description
Anika Therapeutics, Inc. is a global, integrated orthopedic medicines company based in Bedford, Massachusetts. Anika is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies along the continuum of care, from palliative pain management to regenerative cartilage repair. Anika's orthopedic medicine portfolio includes ORTHOVISC, MONOVISC, and CINGAL, which alleviate pain and restore joint function by replenishing depleted HA, and HYALOFAST, a solid HA-based scaffold to aid cartilage repair and regeneration.